Do not allow short term volatile price fluctuations by a

New Post Public Reply Private Reply Replies (2) Message Board
EliteYoda SCARFIZI55 #5954

Do not allow short term volatile price fluctuations by a few market players to alter your long term sentiment on the prospects for the company. The company does NOT equate to the stock, they are totally seperate.

"The only way I'd accept this Diluting is if its monies needed to run a FAT PROMO campaign to a PENNY!!!!"

Think about what you are saying there, it is rather obtuse. First you implictly assume that anytime there is a downturn in the PPS on higher than average volume, it is necessarily being caused by the company diluting and directly selling shares into the market. This is a faulty assumption. We can monitor the O/S by calling or emailing the T/A at anytime (obviously there is a few days delay from when any dilution occurs to when they report new share structure numbers); but it is knowable. The PPS does not just move up in a straight line, once in a while there is heavy selling in the market, stocks move and down, that is how it goes. Are you saying that as a long it would actually make you feel better about the PPS downturn if you heard that the company was diluting so that they could use those funds raised to instigate a stock ad promo campaign run?!!! In my opinion, that is really a negative way to look at the company and management. That would be a rather shady business practice and it would make the company look like another PK share selling scheme, which it is not. I think perhaps all the basher dilution rants have gotten to you?! The fact is, no one can know exactly who is selling or what has really happened with all the shares until we can see for ourselves an audited 10K document. It's all speculation, otherwise. Most of the time, posters are just simply spewing guesses and negative commentary on the principles in RFMK, bashing them personally which is very nasty. Amazing what some people will say on a public message board. Sad, really.

I would agree that shareholders have always needed the transparency that a 10K provides. That is primarily what we are all waiting for, but as I have said, it takes time and we do not even know yet if the auditors have been given the document to begin their work and an audit may take several weeks, so I for one am not waiting day after day hoping to see a 10K pop up in EDGAR, I am merely hoping that it does eventually get filed before the Nov elections.

When speculating and musing what could have been the causes of any PPS downturn, anyone can come up with a myriad plausible explanations. It does not mean any of them are true. For instance, no one today seems to be talking about the fact that there was a huge market rout today with the indices plummeting which can wreak havoc on investors accounts causing them to have to possibly deal with margin calls and margin pressure which instigates dumping of all kinds, especially those holdings which are very speculative and already in the green. Who knows, this could have caused a few big holders to have to shed some of their positions in RFMK (forced selling) and again on a slow Friday with a lack of buyers present, possibly in low liquidity the MMs just took their shares off their hands but would only do it for a significant discount to yesterdays price. It happens. I do however like the fact that volume picked up, 60M shares intraday is a much better volume level, even if it did sell off a bit from above the 200 DMA. As I have said for many weeks, the 200 DMA in ANY stock is a much more stiff level for the market to negotiate than many expect. It takes a lot for any stock to shake off the 200 DMA resistance level and move higher. Only a large volume of buyers can do that and so far, at least in RFMK, we have not seen new buyers lately. Though HEMP and the other MJ stocks are starting to see that, look at HEMPs gains today! It's another reason to own them all!!!

GLTY

$RFMK! 

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 319

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 283

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 81

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 246

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

Sonic Partners with Obsessed Garage for Home Garage Solutions

Updated Category News Views 147

Sonic Teams Up with Obsessed Garage to Transform Home Garages Sonic, a front-runner in delivering high-quality tool solutions and equipment, has recently announced an exciting partnership with Obsessed Garage. This collaboration aims to cater to home garage enthusiasts who demand tools and storage solutions that match the quality standards utilized by professionals in the...

Continue Reading
Investors of Sun Communities, Inc. Urged to Act Before Deadline

Updated Category News Views 167

Important Update for Sun Communities, Inc. Investors There is a significant call to action for investors of Sun Communities, Inc. as a class action lawsuit has been filed against the company, urging those affected to act promptly. This is a crucial moment for investors who purchased securities from the company during a specific period. Legal representation is being...

Continue Reading
XOMA Stock Reaches New Heights: Key Developments and Insights

Updated Category News Views 67

XOMA Stock Performance Overview XOMA Ltd's stock has recently made headlines by reaching a remarkable 52-week high, with shares trading at an impressive $30.49. This achievement not only signifies a significant milestone for the company but also highlights a robust year-over-year growth that can't be overlooked. Investors have observed a substantial increase of 73.82% in...

Continue Reading
Evolv Technologies Faces Turmoil with Executive Departures

Updated Category News Views 230

Evolv Technologies Faces Turmoil with Executive Departures Evolv Technologies Holdings (NASDAQ: EVLV) is navigating turbulent times following the resignation of its Chief Financial Officer, Mark Donohue. His departure comes amid serious allegations of improper revenue recognition practices that have raised questions about the company's integrity and financial health....

Continue Reading
Editas Medicine: Financial Insights and Market Strategies Revealed

Updated Category News Views 56

Editas Medicine Maintains Price Target Amidst Financial Developments Recently, Leerink Partners reaffirmed a Market Perform rating for Editas Medicine (NASDAQ: EDIT), keeping a price target steady at $8.00. This decision comes closely after the company announced a substantial financing agreement with DRI Healthcare Trust. Under this agreement, Editas is set to receive an...

Continue Reading